Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1981 2
1985 1
1988 2
1989 3
1990 1
1992 2
1993 3
1994 6
1995 9
1996 11
1997 15
1998 29
1999 21
2000 38
2001 56
2002 52
2003 77
2004 120
2005 131
2006 123
2007 125
2008 162
2009 173
2010 210
2011 250
2012 340
2013 372
2014 328
2015 349
2016 379
2017 383
2018 399
2019 395
2020 469
2021 542
2022 507
2023 478
2024 493
2025 549
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,763 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
Morand EF, Furie R, Tanaka Y, Bruce IN, Askanase AD, Richez C, Bae SC, Brohawn PZ, Pineda L, Berglind A, Tummala R; TULIP-2 Trial Investigators. Morand EF, et al. Among authors: bae sc. N Engl J Med. 2020 Jan 16;382(3):211-221. doi: 10.1056/NEJMoa1912196. Epub 2019 Dec 18. N Engl J Med. 2020. PMID: 31851795 Clinical Trial.
The 2024 APLAR Consensus on the Management of Lupus Nephritis.
Mok CC, So H, Hamijoyo L, Kasitanon N, Chen Y, Bae SC, Li MT, Navarra S, Yap DYH, Tanaka Y. Mok CC, et al. Among authors: bae sc. Int J Rheum Dis. 2025 Jan;28(1):e70021. doi: 10.1111/1756-185X.70021. Int J Rheum Dis. 2025. PMID: 39744836 Review.
ERN ReCONNET-SLICC-SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations.
Arnaud L, Ruiz-Irastorza G, Aranow C, Bernatsky S, Dall'Era M, Adelowo O, Bae SC, Beretta L, Bonfa E, Cervera R, Chasset F, Clarke AE, Costedoat-Chalumeau N, Doria A, Espinosa G, Fanouriakis A, Fredi M, Gatto M, Gladman DD, Gomez-Puerta JA, Inanç M, Ines LS, Isenberg D, Izuka S, Khmelinskii N, Legge A, Macieira C, Monticielo OA, Morand EF, Muñoz-Louis R, Padjen I, Petri M, Piga M, Pons-Estel BA, Ramirez GA, Ramsey-Goldman R, Richez C, Sciascia S, Toro-Gutierrez CE, Van Vollenhoven RF, Vital EM, Gerosa M, Touma Z, Mosca M, Tani C; European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal, Diseases; Systemic Lupus Erythematosus International Collaborating Clinics group; European Lupus Society rare systemic lupus erythematosus taskforce member panel. Arnaud L, et al. Among authors: bae sc. Lancet Rheumatol. 2025 Jul;7(7):e505-e518. doi: 10.1016/S2665-9913(25)00063-3. Epub 2025 May 23. Lancet Rheumatol. 2025. PMID: 40418946 Review.
Whole-genome landscapes of 1,364 breast cancers.
Kim R, Yu J, Lim J, Oh BB, Nam SJ, Kim SW, Lee JE, Chae BJ, Kim JY, Park GE, Kang BJ, Paik PS, Bae SY, Yoon CI, Lee YJ, Kim D, Shin K, Lee JE, Kang J, Lee A, Connolly-Strong E, Lee S, Lee BR, Lee Y, Yi KJ, Kwon YO, Chun IH, Park J, Kim J, Choi C, Shin JY, Lee H, Kim M, Park H, Jeong I, Yi B, Lee WC, Lee JS, Park WC, Kim SH, Choi YL, Lee J, Ju YS, Park YH. Kim R, et al. Among authors: bae sy. Nature. 2025 Dec 3. doi: 10.1038/s41586-025-09812-3. Online ahead of print. Nature. 2025. PMID: 41339552
6,763 results